This is our ongoing reporting on how AI is being integrated into healthcare technology. We are seeking out the thought leaders and innovations that are moving the needle forward which include ANSI, Canon Medical, FDA, Abiomed, IBH Population Health Solutions, Lyssn, Endpoint Health, Genial Technology, & Frost & Sullivan.Read More
By JoNel Aleccia & Anna Maria Barry-Jester – “Save your business while saving lives,” reads the website of Because Health, a Seattle tech startup selling two types of tests to employers willing to pay $350 a pop to learn whether their workers have been infected with COVID-19.
New On Demand Dr. Nick: The Incrementalist: With guest Amy Abernethy, MD, Ph.D. the Principal Deputy Commissioner & Acting CIO for the FDA. We had talked in January at CES about the forthcoming meeting focused on the FDA’s Technology Modernization Action Plan but as a result of the COVID19 pandemic, the meeting was postponed to Jun 30.
We’ve rounded up some of the latest news and announcements pertaining to the coronavirus and the healthcare industry.
By Christina Jewett – FDA Commissioner Scott Gottlieb announced in a tweet recently that the agency plans to release hundreds of thousands, if not millions, of previously unpublished injury and malfunction reports tied to about 100 medical devices.
By Shefali Luthra – In an almost uniform response to the impending exit of Food and Drug Administration Commissioner Scott Gottlieb, city and county public health officials are urging the Trump administration to go bigger in its response to adolescents’ growing use of e-cigarettes.
FDA Commissioner Scott Gottlieb announced he will be leaving his position next month. The White House has confirmed a resignation was not requested. Reason for departure only states that he wants to spend more time with his family.
Seth L. Sherman, MD, a sports medicine orthopaedic surgeon at University of Missouri Health Care’s Missouri Orthopaedic Institute, recently became one of the first American…
By Kayla Matthews – Since 1976, the U.S. Food and Drug Administration (FDA) has offered a fast-track approval process for medical device manufacturers that could prove their products were substantially similar to approved items that were already in the marketplace.